CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 51 enrolled
Drug / intervention
comfilcon A +3 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02510820
NCT02510820N/ACompleted
CompareCT.gov

The Clinical Performance of the Biofinity Contact Lens (Comfilcon A) With Two Lens Care Systems

CooperVision, Inc.·interventional·Posted Jul 29, 2015·Updated Feb 1, 2017

In Brief

A clinical study evaluating comfilcon A, Synergi, and 2 other interventions for Myopia. Completed, enrolled 51 participants across 1 site.

Detailed Summary

This will be a controlled and randomized, single-masked, crossover study in which 48 subjects will use the Biofinity Contact Lens (comfilcon A) with each of the two lens care products ('solutions'), (Synergi and Biotrue Multi-purpose Solution) for one month each. Follow-up visits for each solution will take place at one week, two weeks and four weeks: with a one-week 'wash-out' period between the solutions. Key outcome measures for this study include biomicroscopic and subjective responses to the lens/solution combinations.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 29, 2015
Enrollment StartMay 1, 2015
Primary CompletionSep 1, 2015
Study CompletionOct 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 10.9 years ago

Interventions

comfilcon Adevice

soft contact lens

Synergidevice

Multipurpose solution

Biotruedevice

Multipurpose solution

stenfilcon Aother

daily disposable contact lenses for washout period